Uyanik, VesileTuglu, CengizGorgulu, YaseminKunduracilar, HakanUyanik, Mehmet Sevki2024-06-122024-06-1220150165-1781https://doi.org/10.1016/j.psychres.2015.05.078https://hdl.handle.net/20.500.14551/22534We aimed to assess the relationship between cytokine levels and the severity of the manic period in medication free patients. 30 Medication free patients and 28 healthy subjects (HS) were recruited. Plasma levels of pro-inflammatory, anti-inflammatory, inflammatory cytokines, and hs-CRP levels were investigated upon hospital admission, after six weeks follow up in bipolar disease manic episode and the results were compared to HS. The severity of the manic episodes was assessed according to the Young mania rating scale. TNF-alpha, INF-gamma, IL-6 and hs-CRP levels were significantly higher in patients with manic episode of bipolar I disorder before treatment than HS. After treatment the levels of TNF-alpha, INF-gamma, IL-6 and hs-CRP were observed to be significantly decreased. There was no difference between the levels of anti-inflammatory cytokines in patients before or after treatment of bipolar disorder and HS. hs-CRP was observed to be the only parameter correlated with clinical response. The most significant outcome of this study is the correlation between clinical outcome and hs-CRP levels in treatment naive manic episode bipolar type I patients. hs-CRP is the most consistent indicator according to pro-inflammatory, inflammatory and anti-inflammatory cytokines, in predicting treatment outcomes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.en10.1016/j.psychres.2015.05.078info:eu-repo/semantics/closedAccessMood DisorderManic EpisodeInflammationAcute PhaseC-Reactive ProteinSerum-LevelsLithiumObesityImpactSchizophreniaInflammationActivationImbalanceSymptomsArticle2283386392Q2WOS:0003602514000232-s2.0-8493873886126160203Q1